Ian N. Foltz

Identification and Characterization of MEDI4736, an Antagonistic Anti–PD-L1 Monoclonal Antibody

Ross Stewart, Michelle Morrow, Scott A. Hammond et al. · Cancer Immunology Research · 2015 · 398 citations

Immunology, Immunoediting, Immunologic Mechanism +20

Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects

Kannan Gunasekaran, Martin Pentony, Min Shen et al. · Journal of Biological Chemistry · 2010 · 279 citations · Full text

Engineering, Immunoengineering, Fc Heterodimer Formation +11

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models

Elizabeth A. Killion, Jinghong Wang, Junming Yie et al. · Science Translational Medicine · 2018 · 217 citations · Full text

Glp-1r Agonists, Anti-obesity Effects, Immunology +20

Treating Diabetes and Obesity with an FGF21-Mimetic Antibody Activating the βKlotho/FGFR1c Receptor Complex

Ian N. Foltz, Sylvia Hu, Chadwick King et al. · Science Translational Medicine · 2012 · 211 citations

Hemopoietic Growth Factors with the Exception of Interleukin-4 Activate the p38 Mitogen-activated Protein Kinase Pathway

Ian N. Foltz, John C. Lee, Peter R. Young et al. · Journal of Biological Chemistry · 1997 · 173 citations · Full text

Interleukin-4 Activate, Immunology, Hemopoietic Growth Factors +20